This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Patrick L. McGeer, PhD, MD; Edith G. McGeer, PhD; Joane S. Suzuki

Arch Neurol. 1977;34(1):33-35.

Abstract
• Measurements on human brain samples of some enzymes concerned with neurotransmitter synthesis suggest serious losses with age. The most severe loss found was that in striatal tyrosine hydroxylase activity, the rate-controlling enzyme in the synthesis of dopamine. Cell counts in the substantia nigra where this dopaminergic tract originates suggest that the decrease in enzyme activity is partly due to cell loss, but must largely reflect decreased activity of residual cells. It is possible that this loss may account for some of the difficulties in movement seen in aged individuals and that it might be less if pigment formation in these cells could be inhibited.

Author Affiliations
From the Kinsmen Laboratory of Neurological Research, Department of Psychiatry, University of British Columbia, Vancouver.

Footnotes
Accepted for publication April 26, 1976.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease.
Zecca et al.
Neurology 2006;67:S8-11.
ABSTRACT | FULL TEXT  

Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Sossi et al.
Brain 2006;129:1050-1058.
ABSTRACT | FULL TEXT  

Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model
de la Fuente-Fernandez et al.
Brain 2004;127:888-899.
ABSTRACT | FULL TEXT  

Progression of gait disorder and rigidity and risk of death in older persons
Wilson et al.
Neurology 2002;58:1815-1819.
ABSTRACT | FULL TEXT  

Dopaminergic Function and Dopamine Transporter Binding Assessed With Positron Emission Tomography in Parkinson Disease
Ribeiro et al.
Arch Neurol 2002;59:580-586.
ABSTRACT | FULL TEXT  

Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour
Zecca et al.
Mol. Pathol. 2001;54:414-418.
ABSTRACT | FULL TEXT  

Gait and Balance Dysfunction: A Model of the Interaction of Age and Disease
Wolfson
Neuroscientist 2001;7:178-183.
ABSTRACT  

Preservation of midbrain catecholaminergic neurons in very old human subjects
Kubis et al.
Brain 2000;123:366-373.
ABSTRACT | FULL TEXT  

Critical decline in fine motor hand movements in human aging
Smith et al.
Neurology 1999;53:1458-1458.
ABSTRACT | FULL TEXT  

The substantia nigra of the human brain: I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D28K immunohistochemistry
Damier et al.
Brain 1999;122:1421-1436.
ABSTRACT | FULL TEXT  

Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods
Am. J. Psychiatry 1998;155:1661-1670.
ABSTRACT | FULL TEXT  

Genetic Classification of Primary Neurodegenerative Disease
Hardy and Gwinn-Hardy
Science 1998;282:1075-1079.
ABSTRACT | FULL TEXT  

Sex Differences in the Striatal Dopamine D2 Receptor Binding Characteristics in Vivo
Pohjalainen et al.
Am. J. Psychiatry 1998;155:768-773.
ABSTRACT | FULL TEXT  

Dose-Dependent Effects of the Dopamine D1 Receptor Agonists A77636 or SKF81297 On Spatial Working Memory in Aged Monkeys
Cai and Arnsten
J. Pharmacol. Exp. Ther. 1997;283:183-189.
ABSTRACT | FULL TEXT  

Behavioral and Neurochemical Effects of Intranigral Administration of Glial Cell Line-Derived Neurotrophic Factor on Aged Fischer 344 Rats
Hebert and Gerhardt
J. Pharmacol. Exp. Ther. 1997;282:760-768.
ABSTRACT | FULL TEXT  

Comparison of Neurologic Changes in 'Successfully Aging' Persons vs the Total Aging Population
Odenheimer et al.
Arch Neurol 1994;51:573-580.
ABSTRACT  

Effect of Age on D2 Dopamine Receptors in Normal Human Brain Measured by Positron Emission Tomography and 11C-Raclopride
Antonini et al.
Arch Neurol 1993;50:474-480.
ABSTRACT  

Reduction of the Substantia Nigra Width and Motor Decline in Aging and Parkinson's Disease
Pujol et al.
Arch Neurol 1992;49:1119-1122.
ABSTRACT  

Magnetic Resonance Evaluation of the Midbrain in Parkinson's Disease
Doraiswamy et al.
Arch Neurol 1991;48:360-360.
ABSTRACT  

DATATOP: A Multicenter Controlled Clinical Trial in Early Parkinson's Disease: Parkinson Study Group
Arch Neurol 1989;46:1052-1060.
ABSTRACT  

Clinical and Pathological Aspects of Parkinsonism in Alzheimer's Disease: A Role for Extranigral Factors?
Morris et al.
Arch Neurol 1989;46:651-657.
ABSTRACT  

The Neurologic Implications of Depression in the Elderly
Brumback
J Geriatr Psychiatry Neurol 1988;1:240-241.
 

Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain
Wong et al.
Science 1984;226:1393-1396.
ABSTRACT  

Decreased CSF Concentrations of Homovanillic Acid and {gamma}-Aminobutyric Acid in Alzheimer's Disease: Age- or Disease-Related Modifications?
Bareggi et al.
Arch Neurol 1982;39:709-712.
ABSTRACT  

Pathogenesis of Parkinson's Disease
Mann and Yates
Arch Neurol 1982;39:545-549.
ABSTRACT  

Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane and Smith
Arch Gen Psychiatry 1982;39:473-481.
ABSTRACT  

Changes in Prevalence, Severity, and Recovery in Tardive Dyskinesia With Age
Smith and Baldessarini
Arch Gen Psychiatry 1980;37:1368-1373.
ABSTRACT  

Hippocampal aging and adrenocorticoids: quantitative correlations
Landfield et al.
Science 1978;202:1098-1102.
ABSTRACT